These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9447756)

  • 1. Immunogenicity and safety of Haemophilus influenzae type b capsular polysaccharide tetanus conjugate vaccine (PRP-T) presented in a dual-chamber syringe with DTP.
    Kanra G; Yurdakök K; Ceyhan M; Ozmert E; Türkay F; Pehlivan T
    Acta Paediatr Jpn; 1997 Dec; 39(6):676-80. PubMed ID: 9447756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and immunogenicity of an Haemophilus influenzae type b-tetanus toxoid conjugate (PRP-T) and diphtheria-tetanus-pertussis (DTP) combination vaccine administered in a dual-chamber syringe to infants in Belgium and Chile.
    Hoppenbrouwers K; Lagos R; Swennen B; Ethevenaux C; Knops J; Levine MM; Desmyter J
    Vaccine; 1998; 16(9-10):921-7. PubMed ID: 9682338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and immunogenicity of Haemophilus influenzae type b-tetanus toxoid conjugate, presented in a dual-chamber syringe with diphtheria-tetanus-pertussis and inactivated poliomyelitis combination vaccine.
    Langue J; Ethevenaux C; Champsaur A; Fritzell B; Bégué P; Saliou P
    Eur J Pediatr; 1999 Sep; 158(9):717-22. PubMed ID: 10485302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the safety and immunogenicity of a five-component acellular pertussis, diphtheria, and tetanus toxoid vaccine (DTaP) when combined with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine (PRP-T) in Taiwanese infants.
    Lee CY; Thipphawong J; Huang LM; Lee PI; Chiu HH; Lin W; Debois H; Harrison D; Xie F; Barreto L
    Pediatrics; 1999 Jan; 103(1):25-30. PubMed ID: 9917435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period.
    Miller MA; Meschievitz CK; Ballanco GA; Daum RS
    Pediatrics; 1995 Apr; 95(4):522-7. PubMed ID: 7700752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine antigen interactions after a combination diphtheria-tetanus toxoid-acellular pertussis/purified capsular polysaccharide of Haemophilus influenzae type b-tetanus toxoid vaccine in two-, four- and six-month-old infants.
    Pichichero ME; Latiolais T; Bernstein DI; Hosbach P; Christian E; Vidor E; Meschievitz C; Daum RS
    Pediatr Infect Dis J; 1997 Sep; 16(9):863-70. PubMed ID: 9306481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and safety of Haemophilus influenzae type b-tetanus protein conjugate vaccine alone or mixed with diphtheria-tetanus-pertussis vaccine in infants.
    Kaplan SL; Lauer BA; Ward MA; Wiedermann BL; Boyer KM; Dukes CM; Schaffer DM; Paisley J; Mendelson R; Pedreira F
    J Pediatr; 1994 Feb; 124(2):323-7. PubMed ID: 8301447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical acceptability and immunogenicity of a pentavalent parenteral combination vaccine containing diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate antigens in two-, four- and six-month-old Chilean infants.
    Lagos R; Kotloff K; Hoffenbach A; San Martin O; Abrego P; Ureta AM; Pines E; Blondeau C; Bailleux F; Levine MM
    Pediatr Infect Dis J; 1998 Apr; 17(4):294-304. PubMed ID: 9576383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of a Haemophilus influenzae type B polysaccharide-tetanus toxoid conjugate vaccine combined with diphtheria, tetanus and pertussis vaccines in Thai infants.
    Chotpitayasunondh T; Panpitpat C; Thisyakorn U; Furer E; Que JU; Hasler T; Cryz SJ
    Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):91-8. PubMed ID: 9322290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity of Haemophilus type b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis vaccine in young infants.
    Watemberg N; Dagan R; Arbelli Y; Belmaker I; Morag A; Hessel L; Fritzell B; Bajard A; Peyron L
    Pediatr Infect Dis J; 1991 Oct; 10(10):758-63. PubMed ID: 1945578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.
    Punjabi NH; Richie EL; Simanjuntak CH; Harjanto SJ; Wangsasaputra F; Arjoso S; Rofiq A; Prijanto M; Julitasari ; Yela U; Herzog C; Cryz SJ
    Vaccine; 2006 Mar; 24(11):1776-85. PubMed ID: 16303216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of combined diphtheria-tetanus-pertussis (whole cell and acellular)-Haemophilus influenzae-b conjugate vaccines administered to Indonesian children.
    Richie E; Punjabi NH; Harjanto SJ; Wangsasaputral F; Sukandar M; Supriatman M; Simanjuntak CH; Que JU; Cryz SJ
    Vaccine; 1999 Mar; 17(11-12):1384-93. PubMed ID: 10195774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children.
    Lehmann D; Kakazo M; Saleu G; Taime J; Javati A; Namuigi P; Alpers MP; Wegmüller B; Zellmeyer M; Fürer E; Que JU; Herzog C
    P N G Med J; 2001; 44(1-2):6-16. PubMed ID: 12418673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine.
    Eskola J; Olander RM; Hovi T; Litmanen L; Peltola S; Käyhty H
    Lancet; 1996 Dec 21-28; 348(9043):1688-92. PubMed ID: 8973430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunogenicity and safety of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in Gambian infants.
    Mulholland EK; Byass P; Campbell H; Fritzell B; Greenwood AM; Todd J; Greenwood BM
    Ann Trop Paediatr; 1994; 14(3):183-8. PubMed ID: 7825990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and safety of a liquid combination of DTP-PRP-T [corrected] vs lyophilized PRP-T reconstituted with DTP.
    Amir J; Melamed R; Bader J; Ethevenaux C; Fritzell B; Cartier JR; Arminjon F; Dagan R
    Vaccine; 1997 Feb; 15(2):149-54. PubMed ID: 9066031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced antibody response in Venezuelan infants immunized with Haemophilus influenzae type b-tetanus toxoid conjugate vaccine.
    Castillo de Febres O; Decker MD; Estopinan M; Bordones G; Edwards KM
    Pediatr Infect Dis J; 1994 Jul; 13(7):635-9. PubMed ID: 7970953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical and immunologic response of Chilean infants to Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine coadministered in the same syringe with diphtheria-tetanus toxoids-pertussis vaccine at two, four and six months of age.
    Ferreccio C; Clemens J; Avendano A; Horwitz I; Flores C; Avila L; Cayazzo M; Fritzell B; Cadoz M; Levine M
    Pediatr Infect Dis J; 1991 Oct; 10(10):764-71. PubMed ID: 1945579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine does not depress serologic responses to diphtheria, tetanus or pertussis antigens when coadministered in the same syringe with diphtheria-tetanus-pertussis vaccine at two, four and six months of age.
    Avendano A; Ferreccio C; Lagos R; Horwitz I; Cayazzo M; Fritzell B; Meschievitz C; Levine M
    Pediatr Infect Dis J; 1993 Aug; 12(8):638-43. PubMed ID: 8414775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Priming effect, immunogenicity and safety of an Haemophilus influenzae type b-tetanus toxoid conjugate (PRP-T) and diphtheria-tetanus-acellular pertussis (DTaP) combination vaccine administered to infants in Belgium and Turkey.
    Hoppenbrouwers K; Kanra G; Roelants M; Ceyhan M; Vandermeulen C; Yurdakök K; Silier T; Dupuy M; Pehlivan T; Ozmert E; Desmyter J
    Vaccine; 1999 Feb; 17(7-8):875-86. PubMed ID: 10067694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.